Literature DB >> 16407229

The novel WD-repeat protein Morg1 acts as a molecular scaffold for hypoxia-inducible factor prolyl hydroxylase 3 (PHD3).

Ulrike Hopfer1, Helmut Hopfer, Katarina Jablonski, Rolf A K Stahl, Gunter Wolf.   

Abstract

Hypoxia-inducible factor-1 (HIF-1), a transcriptional complex composed of an oxygen-sensitive alpha- and a beta-subunit, plays a pivotal role in cellular adaptation to low oxygen availability. Under normoxia, the alpha-subunit of HIF-1 is hydroxylated by a family of prolyl hydroxylases (PHDs) and consequently targeted for proteasomal degradation. Three different PHDs have been identified, but the difference among their in vivo roles remain unclear. PHD3 is strikingly expressed by hypoxia, displays high substrate specificity, and has been identified in other signaling pathways. PHD3 may therefore hydroxylate divergent substrates and/or connect divergent cellular responses with HIF. We identified a novel WD-repeat protein, recently designated Morg1 (MAPK organizer 1), by screening a cDNA library with yeast two-hybrid assays. The interaction between PHD3 and Morg1 was confirmed in vitro and in vivo. We found seven WD-repeat domains by cloning the full-length cDNA of Morg1. By confocal microscopy both proteins co-localize within the cytoplasm and the nucleus and display a similar tissue expression pattern in Northern blots. Binding occurs at a conserved region predicted to the top surface of one propeller blade. Finally, HIF-mediated reporter gene activity is decreased by Morg1 and reduced to basal levels when Morg1 is co-expressed with PHD3. Suppression of Morg1 or PHD3 by stealth RNA leads to a marked increase of HIF-1 activity. These results indicate that Morg1 specifically interacts with PHD3 most likely by acting as a molecular scaffold. This interaction may provide a molecular framework between HIF regulation and other signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16407229     DOI: 10.1074/jbc.M513751200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases.

Authors:  Vaithinathan Selvaraju; Narasimham L Parinandi; Ram Sudheer Adluri; Joshua W Goldman; Naveed Hussain; Juan A Sanchez; Nilanjana Maulik
Journal:  Antioxid Redox Signal       Date:  2013-10-31       Impact factor: 8.401

Review 2.  Cellular oxygen sensing in health and disease.

Authors:  David R Mole; Peter J Ratcliffe
Journal:  Pediatr Nephrol       Date:  2007-10-23       Impact factor: 3.714

Review 3.  Hypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress.

Authors:  Ambreena Siddiq; Leila R Aminova; Rajiv R Ratan
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

4.  Raf family kinases: old dogs have learned new tricks.

Authors:  David Matallanas; Marc Birtwistle; David Romano; Armin Zebisch; Jens Rauch; Alexander von Kriegsheim; Walter Kolch
Journal:  Genes Cancer       Date:  2011-03

5.  Bidirectional regulation between WDR83 and its natural antisense transcript DHPS in gastric cancer.

Authors:  Wen-Yu Su; Jiong-Tang Li; Yun Cui; Jie Hong; Wan Du; Ying-Chao Wang; Yan-Wei Lin; Hua Xiong; Ji-Lin Wang; Xuan Kong; Qin-Yan Gao; Li-Ping Wei; Jing-Yuan Fang
Journal:  Cell Res       Date:  2012-04-10       Impact factor: 25.617

Review 6.  Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing.

Authors:  James D Webb; Mathew L Coleman; Christopher W Pugh
Journal:  Cell Mol Life Sci       Date:  2009-09-12       Impact factor: 9.261

7.  Rapid degradation of hypoxia-inducible factor-1alpha by KRH102053, a new activator of prolyl hydroxylase 2.

Authors:  H J Choi; B-J Song; Y-D Gong; W J Gwak; Y Soh
Journal:  Br J Pharmacol       Date:  2008-03-10       Impact factor: 8.739

8.  Immunoproteomic identification of bovine pericardium xenoantigens.

Authors:  Leigh G Griffiths; Leila H Choe; Kenneth F Reardon; Steven W Dow; E Christopher Orton
Journal:  Biomaterials       Date:  2008-06-02       Impact factor: 12.479

9.  Advanced glycated end-products affect HIF-transcriptional activity in renal cells.

Authors:  Tzvetanka Bondeva; Juliane Heinzig; Carola Ruhe; Gunter Wolf
Journal:  Mol Endocrinol       Date:  2013-09-12

10.  Sprouty2 Protein Regulates Hypoxia-inducible Factor-α (HIFα) Protein Levels and Transcription of HIFα-responsive Genes.

Authors:  Kristin C Hicks; Tarun B Patel
Journal:  J Biol Chem       Date:  2016-06-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.